ImmunologybioRxiv
Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1 infected individuals
M. Uzzan, M. Tokuyama, A. K. Rosenstein…·S. Mehandru
Anti-α4β7 therapy reduces lymphoid aggregates in the gastrointestinal tract of HIV-1 infected individuals with mild inflammatory bowel disease.
DOI 10.1126/scitranslmed.aau4711